Please login to the form below

Not currently logged in
Email:
Password:

pediatrics

This page shows the latest pediatrics news and features for those working in and with pharma, biotech and healthcare.

Morning brief: Herzuma launched in Europe, rare disease status for Orchard candidate and more

Morning brief: Herzuma launched in Europe, rare disease status for Orchard candidate and more

Orchard gains rare disease status for ex-GSK therapy. Orchard Therapeutics has been granted an FDA Rare Pediatric Disease Designation for its rare disease gene therapy candidate OTL-200, which it

Latest news

More from news
Approximately 1 fully matching, plus 23 partially matching documents found.

Latest Intelligence

  • Implementing eHealth innovation Implementing eHealth innovation

    The first results from the global, five-year observational study in children with growth disorders was presented at the 10th International Meeting of Pediatric Endocrinology in September 2017.

  • Paging Dr Millennial Paging Dr Millennial

    Almost 50% of the world's population today is under 25 years old, which means that family planning, women's health and pediatrics will be growing elements of the world's

  • Pharma deals in August 2015 Pharma deals in August 2015

    In 2012 the PRV programme was extended to include rare pediatric diseases and the emergence of trading in PRVs was noted in our last annual Deal Watch report.

  • Pharma deals during November 2014 Pharma deals during November 2014

    In 2012 the PRV programme was extended to include rare pediatric diseases. ... BioMarin was awarded a Rare Pediatric Disease PRV when it received approval of Vimizim, a new biological product for patients with Mucopolysaccharidosis type IVA.

  • Pharma deals during March 2013 Pharma deals during March 2013

    825. Edison Pharmaceuticals/ Dainippon Sumitomo. Licence. EPI-743 (orphan pediatric mitochondrial disease) and EPI-589 (adult CNS disease) (phase II).

More from intelligence
Approximately 0 fully matching, plus 5 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest from PMHub

  • Mastering the precision medicine opportunity

    Last year the FDA made a pioneering move in this space and  approved Keytruda for use in adult and pediatric patients with unresectable or metastatic, microsatellite instability-high (MSI-H) or

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Anthill Agency

Digital communications agency empowering clients through their digital transformation journey. Whether through training, delivering solutions or devising digital strategies, we...

Latest intelligence

PM Society Digital Awards – the power of together
Our chief executive, Emma Statham, writes about the value of awards and the power of together....
Seduction_feature_image_thumb.jpg
Seduce anyone in four simple steps
You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...
What Would Jeremy Do? : Assessing the impact of a Corbyn-led Labour government
GK Strategy are delighted to announce the launch our latest briefing paper entitled ‘What Would Jeremy Do? Assessing the impact of a Corbyn-led Labour government’....

Infographics